Welcome to CDC Stacks | Interim guidance for medical screening and hazard surveillance for workers potentially exposed to engineered nanoparticles - 5202 | Stephen B. Thacker CDC Library collection | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Interim guidance for medical screening and hazard surveillance for workers potentially exposed to engineered nanoparticles
  • Published Date:
    February, 2009
  • Status:
    current
Filetype[PDF - 17.97 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
Interim guidance for medical screening and hazard surveillance for workers potentially exposed to engineered nanoparticles
Details:
  • Corporate Authors:
    National Institute for Occupational Safety and Health ; Nanotechnology Research Center (National Institute for Occupational Safety and Health) ;
  • Series:
    NIOSH current intelligence bulletin ; 60
    DHHS publication ; no. (NIOSH) 2009-116
  • Document Type:
  • Description:
    Foreword -- Executive summary -- Acknowledgements -- Introduction. -- Background: brief review of the literature -- Occupational health surveillance -- Discussion and conclusions -- Recommendations. -- References -- Appendix A: Critical Aspects of an Occupational Medical Screening Program -- Appendix B: OSHA standards that include requirements for medical surveillance -- Appendix C: Hazards for which NIOSH has recommended the use of medical surveillance -- Appendix D: Discussion of occupational health surveillance programs with medical screening. -- Appendix E: Examples of limitations in the evidence base for specific medical screening of workers exposed to engineered nanoparticles -- Appendix F: Exposure registries

    Concerns have been raised about whether workers exposed to engineered nanoparticles are at increased risk of adverse health effects. The current body of evidence about the possible health risks of occupational exposure to engineered nanoparticles is quite small. While there is increasing evidence to indicate that exposure to some engineered nanoparticles can cause adverse health effects in laboratory animals, no health studies of workers exposed to the few engineered nanoparticles tested in animals have been published. The purpose of this document from the National Institute for Occupational Safety and Health (NIOSH) is to provide interim guidance about whether specific medical screening, including performing medical tests on asymptomatic workers, is appropriate for these workers. Medical screening is only one part of what should be considered a complete safety and health management program. An ideal safety and health management program follows a hierarchy of controls and involves various occupational health surveillance measures. Since specific medical screening of asymptomatic workers exposed to engineered nanoparticles has not been extensively discussed in the scientific literature, this document makes recommendations based upon what is known until more rigorous research can be performed. Currently there is insufficient scientific and medical evidence to recommend the specific medical screening of workers potentially exposed to engineered nanoparticles. Nonetheless, this lack of evidence does not preclude specific medical screening by employers interested in taking precautions beyond existing industrial hygiene measures. If nanoparticles are composed of a chemical or bulk material for which medical screening recommendations exist, these same screening recommendations would be applicable for workers exposed to engineered nanoparticles as well. As research into the hazards of engineered nanoparticles continues, vigilant reassessment of available data is critical to determine whether specific medical screening is warranted for workers. In the interim, the following recommendations are provided for workplaces where workers may be exposed to engineered nanoparticles in the course of their work: 1. Take prudent measures to control exposures to engineered nanoparticles. 2. Conduct hazard surveillance as the basis for implementing controls. 3. Continue use of established medical surveillance approaches. NIOSH will continue to collect and evaluate new research findings and update its recommendations about medical screening programs for workers exposed to nanoparticles. NIOSH will also continue to consider the strengths and weaknesses of establishing exposure registries for workers potentially exposed to engineered nanoparticles for future health surveillance and epidemiological studies.

    NIOSHTIC No 20090201

  • Supporting Files:
    No Additional Files